Magnetic resonance versus technetium-99m pyrophosphate scintigraphy in the detection of perioperative myocardial necrosis;Ressonância magnética vs cintilografia com pirofosfato marcado com tecnécio-99m para a detecção de necrose miocárdica perioperatória

Arquivos Brasileiros de Cardiologia

Volumn 91, Issue 2, 2008, Pages

  Monte, Guilherme Urpia ^a,b   Drager, Luciano Ferreira ^a   Souza, Fábio Solano De Freitas ^a   De Ávila, Luiz Francisco Rodrigues ^a   Parga Filho, José Rodrigues ^a   César, Luiz Antônio Machado ^a   Izaki, Marisa ^a   Meneghetti, José Cláudio ^a   Rochitte, Carlos Eduardo ^a   Kalil Filho, Roberto ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b Setor Sudoeste ^*  (Brazil)

Author keywords

Comparative studies; Magnetic resonance imaging; Myocardial infarction surgery; Myocardial revascularization; Myocardial radionuclide imaging; Technetium Tc99m pyrophosphate

Indexed keywords

BIOCHEMICAL MARKER; TROPONIN I; BIOLOGICAL MARKER; CREATINE KINASE MB; DIAGNOSTIC AGENT; PYROPHOSPHATE TECHNETIUM TC 99M; RADIOPHARMACEUTICAL AGENT;

ADULT; AGED; ARTERY DISEASE; ARTICLE; CHRONIC DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; FEMALE; HEART INFARCTION; HEART MUSCLE NECROSIS; HEART SCINTISCANNING; HUMAN; INTERMETHOD COMPARISON; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; BLOOD; COMPARATIVE STUDY; CORONARY ARTERY DISEASE; HEART MUSCLE REVASCULARIZATION; MIDDLE AGED; NECROSIS; PATHOLOGY; PEROPERATIVE COMPLICATION; SCINTISCANNING; SENSITIVITY AND SPECIFICITY;

BIOLOGICAL MARKERS; CHRONIC DISEASE; CORONARY DISEASE; CREATINE KINASE, MB FORM; FEMALE; HUMANS; INTRAOPERATIVE COMPLICATIONS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; MYOCARDIAL REVASCULARIZATION; NECROSIS; RADIOPHARMACEUTICALS; SENSITIVITY AND SPECIFICITY; TECHNETIUM TC 99M PYROPHOSPHATE; TROPONIN I;

EID: 49749123014     PISSN: 0066782X     EISSN: 16784170     Source Type: Journal    
DOI: 10.1590/S0066-782X2008001400009     Document Type: Article

References (21)

1. Namay DL, Hammermeister KE, Zia MS, DeRouen TA, Dodge HT, Namay K. Effect of perioperative myocardial infarction on late survival in patients undergoing coronary artery bypass surgery. Circulation. 1982; 65: 1066-71.
2. Schaff HV, Gersh BJ, Fisher LD, Frye RL, Mock MB, Ryan TJ, et al. Detrimental effect of perioperative myocardial infarction on late survival after coronary artery bypass. Report from the Coronary Artery Surgery Study - CASS. J Thorac Cardiovasc Surg. 1984; 88: 972-81.
3. McGregor CG, Muir AL, Smith AF, Miller HC, Hannan WJ, Cameron EW, et al. Myocardial infarction related to coronary artery bypass graft surgery. Br Heart J. 1984; 51: 399-406.
4. Guiteras VP, Pelletier LC, Hernandez MG, Jais JM, Chaitman BR, Dupras G, et al. Diagnostic criteria and prognosis of perioperative myocardial infarction following coronary bypass. J Thorac Cardiovasc Surg. 1983; 86: 878-86.
5. Costa MA, Carere RG, Lichtenstein SV, Foley DP, de Valk V, Lindenboom W, et al. Incidence, predictors, and significance of abnormal cardiac enzyme rise in patients treated with bypass surgery in the arterial revascularization therapies study (ARTS). Circulation. 2001; 104: 2689-93.
6. Burns RJ, Gladstone PJ, Tremblay PC, Feindel CM, Salter DR, Lipton IH, et al. Myocardial infarction determined by technetium-99m pyrophosphate single-photon tomography complicating elective coronary artery bypass grafting for angina pectoris. Am J Cardiol. 1989; 63: 1429-34.
7. Jain U. Myocardial infarction during coronary artery bypass surgery. J Cardiothorac Vasc Anesth. 1992; 6: 612-23.
8. Platt MR, Mills LJ, Parkey RW, Willerson JT, Bonte FJ, Shapiro W, et al. Perioperative myocardial infarction diagnosed by technetium 99m stannous pyrophosphate myocardial scintigrams. Circulation. 1976; 54: III24-III27.
9. Codini MA, Turner DA, Battle WE, Hassan P, Ali A, Messer JV. Value and limitations of technetium-99m stannous pyrophosphate in the detection of acute myocardial infarction. Am Heart J. 1979; 98: 752-62.
10. Simonetti OP, Kim RJ, Fieno DS, Hillenbrand HB, Wu E, Bundy JM, et al. An improved MR imaging technique for the visualization of myocardial infarction. Radiology. 2001; 218: 215-23.
11. Wu E, Judd RM, Vargas JD, Klocke FJ, Bonow RO, Kim RJ. Visualisation of presence, location, and transmural extent of healed Q-wave and non-Qwave myocardial infarction. Lancet. 2001; 357: 21-8.
12. Ricciardi MJ, Wu E, Davidson CJ, Choi KM, Klocke FJ, Bonow RO, et al. Visualization of discrete microinfarction after percutaneous coronary intervention associated with mild creatine kinase-MB elevation. Circulation. 2001; 103: 2780-3.
13. Kim RJ, Fieno DS, Parrish TB, Harris K, Chen EL, Simonetti O, et al. Relationship of MRI delayed contrast enhancement to irreversible injury, infarct age, and contractile function. Circulation. 1999; 100: 1992-2002.
14. Wagner A, Mahrholdt H, Holly TA, Elliott MD, Regenfus M, Parker M, et al. Contrast-enhanced MRI and routine single photon emission computed tomography (SPECT) perfusion imaging for detection of subendocardial myocardial infarcts: an imaging study. Lancet. 2003; 361: 374-9.
15. Mahrholdt H, Wagner A, Holly TA, Elliott MD, Bonow RO, Kim RJ, et al. Reproducibility of chronic infarct size measurement by contrast-enhanced magnetic resonance imaging. Circulation. 2002; 106: 2322-7.
16. Cerqueira MD, Weissman NJ, Dilsizian V, Jacobs AK, Kaul S, Laskey WK, et al. Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart: a statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association. Circulation. 2002; 105: 539-42.
17. Califf RM, Abdelmeguid AE, Kuntz RE, Popma JJ, Davidson CJ, Cohen EA, et al. Myonecrosis after revascularization procedures. J Am Coll Cardiol. 1998; 31: 241-51.
18. Sato H, Murakami Y, Shimada T, Ochiai K, Kitamura J, Sano K, et al. Detection of right ventricular infarction by gadolinium DTPA-enhanced magnetic resonance imaging. Eur Heart J. 1995; 16: 1195-9.
19. Monte GU. Detecção de infarto do miocárdio perioperatório pela ressonância magnética em pacientes submetidos a cirurgia de revascularização miocárdica [tese]. São Paulo: Faculdade de Medicina da Universidade de São Paulo; 2007.
20. Gavard JA, Chaitman BR, Sakai S, Stocke K, Danchin N, Erhardt L, et al. Prognostic significance of elevated creatine kinase MB after coronary bypass surgery and after an acute coronary syndrome: results from the GUARDIAN trial. J Thorac Cardiovasc Surg. 2003; 126: 807-13.
21. Foo TK, Stanley DW, Castillo E, Rochitte CE, Wang Y, Lima JA, et al. Myocardial viability: breath-hold 3D MR imaging of delayed hyperenhancement with variable sampling in time. Radiology. 2004; 230: 845-51.